279 related articles for article (PubMed ID: 12576087)
1. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 at the mouse melanocortin receptors. Part 3: modifications at the Arg position.
Holder JR; Xiang Z; Bauzo RM; Haskell-Luevano C
Peptides; 2003 Jan; 24(1):73-82. PubMed ID: 12576087
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position.
Holder JR; Xiang Z; Bauzo RM; Haskell-Luevano C
J Med Chem; 2002 Dec; 45(26):5736-44. PubMed ID: 12477357
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors: part 2 modifications at the Phe position.
Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C
J Med Chem; 2002 Jul; 45(14):3073-81. PubMed ID: 12086493
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors. 1. Modifications at the His position.
Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C
J Med Chem; 2002 Jun; 45(13):2801-10. PubMed ID: 12061882
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
[TBL] [Abstract][Full Text] [Related]
6. N-terminal fatty acylated His-dPhe-Arg-Trp-NH(2) tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes.
Todorovic A; Holder JR; Bauzo RM; Scott JW; Kavanagh R; Abdel-Malek Z; Haskell-Luevano C
J Med Chem; 2005 May; 48(9):3328-36. PubMed ID: 15857138
[TBL] [Abstract][Full Text] [Related]
7. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
8. Characterization of melanocortin NDP-MSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors.
Haskell-Luevano C; Holder JR; Monck EK; Bauzo RM
J Med Chem; 2001 Jun; 44(13):2247-52. PubMed ID: 11405661
[TBL] [Abstract][Full Text] [Related]
9. Characterization of aliphatic, cyclic, and aromatic N-terminally "capped" His-D-Phe-Arg-Trp-NH2 tetrapeptides at the melanocortin receptors.
Holder JR; Marques FF; Xiang Z; Bauzo RM; Haskell-Luevano C
Eur J Pharmacol; 2003 Feb; 462(1-3):41-52. PubMed ID: 12591094
[TBL] [Abstract][Full Text] [Related]
10. D-Amino acid scan of gamma-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity.
Grieco P; Balse PM; Weinberg D; MacNeil T; Hruby VJ
J Med Chem; 2000 Dec; 43(26):4998-5002. PubMed ID: 11150170
[TBL] [Abstract][Full Text] [Related]
11. Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity.
Joseph CG; Wilczynski A; Holder JR; Xiang Z; Bauzo RM; Scott JW; Haskell-Luevano C
Peptides; 2003 Dec; 24(12):1899-908. PubMed ID: 15127941
[TBL] [Abstract][Full Text] [Related]
12. StructureâğActivity Relationships of the Tetrapeptide Ac-His-Arg-(
Schlasner KN; Ericson MD; Doering SR; Freeman KT; Weinrich M; Haskell-Luevano C
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013889
[TBL] [Abstract][Full Text] [Related]
13. Melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 modified at the para position of the benzyl side chain (DPhe): importance for mouse melanocortin-3 receptor agonist versus antagonist activity.
Proneth B; Pogozheva ID; Portillo FP; Mosberg HI; Haskell-Luevano C
J Med Chem; 2008 Sep; 51(18):5585-93. PubMed ID: 18800761
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a Pan-Melanocortin Receptor Antagonist [Ac-DPhe(pI)-Arg-Nal(2')-Orn-NH
Ericson MD; Tran LT; Mathre SS; Freeman KT; Holdaway K; John K; Lunzer MM; Bouchard JL; Haskell-Luevano C
J Med Chem; 2023 Jun; 66(12):8103-8117. PubMed ID: 37307241
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Mixed Pharmacology Melanocortin-3 Agonists and Melanocortin-4 Receptor Tetrapeptide Antagonist Compounds (TACOs) Based on the Sequence Ac-Xaa
Doering SR; Freeman KT; Schnell SM; Haslach EM; Dirain M; Debevec G; Geer P; Santos RG; Giulianotti MA; Pinilla C; Appel JR; Speth RC; Houghten RA; Haskell-Luevano C
J Med Chem; 2017 May; 60(10):4342-4357. PubMed ID: 28453292
[TBL] [Abstract][Full Text] [Related]
16. Structure activity studies of the melanocortin antagonist SHU9119 modified at the 6, 7, 8, and 9 positions.
Haskell-Luevano C; Lim S; Yuan W; Cone RD; Hruby VJ
Peptides; 2000 Jan; 21(1):49-57. PubMed ID: 10704719
[TBL] [Abstract][Full Text] [Related]
17. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
[TBL] [Abstract][Full Text] [Related]
18. A Macrocyclic Agouti-Related Protein/[Nle
Ericson MD; Freeman KT; Schnell SM; Haskell-Luevano C
J Med Chem; 2017 Jan; 60(2):805-813. PubMed ID: 28045525
[TBL] [Abstract][Full Text] [Related]
19. Modified melanocortin tetrapeptide Ac-His-dPhe-Arg-Trp-NH at the arginine side chain with ureas and thioureas.
Joseph CG; Sorensen NB; Wood MS; Xiang Z; Moore MC; Haskell-Luevano C
J Pept Res; 2005 Nov; 66(5):297-307. PubMed ID: 16218996
[TBL] [Abstract][Full Text] [Related]
20. Aza-scanning of the potent melanocortin receptor agonist Ac-His-D-Phe-Arg-Trp-NH.
Boeglin D; Xiang Z; Sorenson NB; Wood MS; Haskell-Luevano C; Lubell WD
Chem Biol Drug Des; 2006 Apr; 67(4):275-83. PubMed ID: 16629825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
